Molloy Moves to the Office of Research and Economic Development

Christopher J. Molloy, who led the Rutgers-UMDNJ integration, has assumed his new role as the university’s senior vice president for research and economic development.

His responsibilities include oversight and strategic planning for the university’s $700 million in annual research expenditures and management of the many institutional offices and resources that support Rutgers’ research and economic development activities.

Molloy had been interim chancellor of Rutgers Biomedical and Health Sciences since last July, after serving as interim provost for biomedical and health sciences for nearly two years.

Under Molloy’s leadership, the Office of Research and Economic Development will expand its commercialization of research through patents, start-ups, and the transfer of technology to industry, maximizing the university’s ability to conduct translational research in the life sciences and other critical research and development activities. It will also promote more public-private partnerships to bring new jobs to New Jersey. And the office will provide enhanced services to foster interdisciplinary collaboration, facilitate corporate contracts, and support the faculty’s submission of grant proposals to governmental and private sponsors.

“This is an exciting time at Rutgers, with so much positive change and potential for growth, and I am very pleased to take on this new position,” Molloy said. “Although much of the conversation here lately has been about biomedical and health sciences, Rutgers has a tremendous amount of talent among the faculty, staff, and students in many, many fields. So it’s a great opportunity to lead this office in new directions that will better support the entire university.”

Molloy succeeds Kenneth J. Breslauer, who had served as interim vice president for research and economic development for nearly a year and a half. Breslauer is returning to his positions as vice president for health sciences partnerships and dean of the division of life sciences.

“Rutgers benefitted greatly from Ken’s willingness to take on this additional responsibility and from his leadership during a period of unprecedented transition for the university,” Molloy said. “I’m grateful for his service and look forward to continuing to work closely with Ken.”

Molloy joined Rutgers in 2007 as dean of the Ernest Mario School of Pharmacy. In October 2011, he was appointed interim provost for biomedical and health sciences and successfully managed the complex integration of Rutgers and most of the former UMDNJ. He received his bachelor’s degree in pharmacy from Rutgers and his doctoral degree from the joint Rutgers Graduate School of Biomedical Sciences at Robert Wood Johnson Medical School/Graduate School–New Brunswick. He was a post-doctoral fellow at the National Cancer Institute.

Prior to joining Rutgers, Molloy held senior research and management positions at Johnson and Johnson Pharmaceutical Research and Development L.L.C., 3-Dimensional Pharmaceuticals Inc., and the Bristol-Myers Squibb Pharmaceutical Research Institute.    11/01/13